IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...
IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA(levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈